Headquartered in Hong Kong, Hua Han specializes in traditional antiaging and antitumor Chinese drugs for women, which it sells under the Yeosure brand.

FORBES: Magazine Article

Hong Kong-listed Hua Han shares sell for ten times their consensus 2006 earnings forecast and have an estimated multiple of just eight for 2007.

FORBES: Correction Appended

Han Ong, regional strategist for Salomon Smith Barney in Hong Kong, says Malaysia had been regarded as a defensive play due to its currency controls and closed current account during the recent global equity meltdown.

CNN: Business: Malaysia's Stock Market